Glycolipopeptide antibodies
US7820797B2 · kind B2 · utility
16Cited by
9References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 3, 2008 |
| Grant date | Oct 26, 2010 |
| Priority date | — |
| Expiry date | Jul 3, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A glycolipopeptide comprising a carbohydrate component, a peptide component and a lipid component, for use as a therapeutic or prophylactic vaccine. Also provided are monoclonal and polyclonal antibodies that recognize the glycolipopeptide of the invention, as well as uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.